Callio therapeutics

Index
Globenewswire

Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer

Globenewswire

Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer

Globenewswire

Callio Therapeutics to Present Phase 1 Trial Design of CLIO-8221, Novel Dual-Payload ADC, at ASCO 2026